In late 2020, BIOS Health launched its Autonomic Therapy Initiative (BIOS ATI), in which it will work with partners to develop AI-powered neural interfaces to deliver treatments for heart disease.
A holistic approach to managing chronic pain focuses on addressing the root cause of discomfort rather than simply masking pain. Join the Peak's email list for the top headlines right in your inbox ...
Neuralace Medical has received US Food and Drug Administration (FDA) clearance of Axon Therapy to treat chronic Painful Diabetic Neuropathy (PDN). This marks the first FDA clearance for a non ...